-
Join JYMed Peptide at Pharmaconex 2025
JYMed Peptide is pleased to invite you to Pharmaconex 2025, taking place from September 1–3, 2025, at the Egypt International Exhibition Center (EIEC) in Cairo. Covering an exhibition area of 12,000+ square meters, the event will host 350+ exhibitors and is expected to attract 8,000+ professiona...Read more -
Join JYMed Peptide at CPhI Korea 2025
JYMed Peptide is delighted to invite you to CPhI Korea 2025, taking place from August 26–28, 2025, at the COEX Convention & Exhibition Center in Seoul. Spanning 15,000 square meters, the event is expected to host more than 450 exhibitors and welcome over 10,000 professional visitors. In 2024...Read more -
Join JYMed at CPHI South East Asia 2025
We’re excited to join industry leaders at CPHI South East Asia 2025, happening from July 16 to 18 at MITEC in Kuala Lumpur. The event spans over 15,000 square meters and will feature around 400 exhibitors. More than 8,000 professionals are expected to attend, along with 60+ seminars and forums f...Read more -
CPHI ShangHai 2025
From June 24 to 26, 2025, the 23rd CPhI China was successfully held at the Shanghai New International Expo Centre!JYMed President Mr. Yao Zhiyong, together with the company’s senior leadership team, attended the event in person. The team engaged directly with the full l...Read more -
Meet JYMed at Interphex Week Tokyo 2025
We’re excited to announce that JYMed will be exhibiting at Interphex Week Tokyo from July 9 to 11, 2025, at Tokyo Big Sight (Ariake). This major event brings together over 90 exhibitors and approximately 34,000 professionals from across the pharmaceutical and cosmetics industries. As one of Asia’...Read more -
Join JYMed at CPHI China 2025
CPHI China 2025 will take place from June 24–26, 2025, at the Shanghai New International Expo Centre (SNIEC). Spanning more than 230,000 square meters, the event is set to host over 3,500 exhibitors and attract more than 100,000 industry professionals. As one of Asia’s largest and most influenti...Read more -
JYMED’S PEPTIDE PRODUCTION BASE IN HUBEI PASSES SECOND CONSECUTIVE FDA INSPECTION
Hubei JXBio Pharmaceutical Co., Ltd., JYMed’s dedicated peptide production site, successfully completed another on-site inspection by the U.S. Food and Drug Administration (FDA) from March 10-14. The inspection, part of a Drug Quality Assurance audit, evaluated key systems including quality, prod...Read more -
JYMED PEPTIDE RECEIVES THREE QUALITY CERTIFICATIONS
JYMed has implemented a robust quality management system, earning three certifications for consistently delivering products and services that meet global standards.The achievement of ISO 9001 certification demonstrates that the company has well-defined processes and standards for internal managem...Read more -
MEET JYMED AT 3 GLOBAL EVENTS IN 2025
We’re excited to join ExpoFarma (Mexico City), IPhEB (St. Petersburg), and In-Cosmetics Global (Amsterdam) in 2025. Come connect with our team and explore collaboration opportunities. Expo Farma 2025 Dates: April 2–4, 2025 Location: World Trade Center, Mexico City Hosted by the Asociación...Read more -
EUROPEAN PATENT GRANTED FOR LIRAGLUTIDE SYNTHESIS
JYMed has been awarded a European patent for its innovative synthesis method of Liraglutide. This milestone highlights our continued leadership in peptide R&D and IP. This patent represents a new process for synthesizing liraglutide, which not only ensures stable yield but also significantly ...Read more -
Exciting News | JYMed Secures DMF Filings for Five New Products in the U.S.
Recently, Shenzhen JYMed Technology Co., Ltd. (hereinafter referred to as “JYMed”) has successfully completed Drug Master File (DMF) filings for five additional products with the U.S. Food and Drug Administration (FDA), further expanding its product portfolio. ABOUT JYMED JYMed is a...Read more -
JYMED Invites You to PCHi 2025 in Guangzhou
JYMED sincerely invites you to join us at the 2025 PCHi Cosmetic Ingredients Exhibition in Guangzhou to explore the latest market trends, innovative technologies, and international regulations. Visit us at Booth 6J07! The 2025 Guan...Read more -
Exciting News | JYMed’s Peptide Production Facility Receives WC Certification
Recently, JYMed’s peptide production facility, Hubei Jianxiang Biopharmaceutical Co., Ltd., received two official documents issued by the Hubei Provincial Drug Administration: the “Drug GMP Compliance Inspection Result Notification” (No. E GMP 2024-258 and No. E GMP 2024-260) a...Read more -
Exciting News | China’s Largest Semaglutide API Production Facility Passes U.S. FDA Inspection
From August 26 to August 30, 2024, JYMed’s peptide production facility, Hubei JX Bio-Pharmaceutical Co., Ltd., successfully passed an on-site inspection conducted by the U.S. Food and Drug Administration (FDA). The inspection covered key areas ...Read more -
2024 CPHI Milan Pharmaceutical Exhibition Recap
01. Exhibition Overview On October 8th, the 2024 CPHI Worldwide Pharmaceutical Exhibition kicked off in Milan. As one of the most important annual events in the global pharmaceutical industry, it attracted participants from 166 countries and regions. With over...Read more -
Exciting News | JYMed’s Liraglutide API Receives WC Certification
On October 12, 2024, JYMed’s Liraglutide API obtained the Written Confirmation (WC) certificate, marking a critical step toward the successful export of the API to the EU market. The WC (Written Confirmation)...Read more -
Exciting News: JYMed’s Leuprorelin Acetate Passes Drug Registration Inspection
Recently, JYMed Technology Co., Ltd. announced that Leuprorelin Acetate, produced by its subsidiary Hubei JX Bio-Pharmaceutical Co., Ltd., has successfully passed the drug registration inspection. Original Drug Market...Read more -
Congratutlation JYMed’s Tirzepatide Completes US-DMF Filing
JYMed Technology Co., Ltd. is pleased to announce that its product, Tirzepatide, has successfully completed the Drug Master File (DMF) registration with the U.S. FDA (DMF Number: 040115) and received the FDA's Acknowl...Read more -
JYMed Attends PCT 2024 in Shanghai
PCT2024 Personal Care Technology Summit & Exhibition is a highly influential event in the Asia-Pacific region, focusing on technology exchange and exhibitions in the personal care products industry.The forum will cover various aspects of the personal care industry, including technological in...Read more -
JYMed Peptide Invites You to Attend the 2024 Korea In-cosmetics Ingredients Exhibition
Location: Korea International Exhibition Center Date: July 24-26, 2024 Time: 10:00 AM – 5:00 PM Address: COEX Exhibition Center Hall C, 513 Yeongdong-daero, Gangnam-gu, Seoul, 06164 In-cosmetics is a leading international exhibition group in the personal care ingredien...Read more
